No OS Signal in Axitinib + Avelumab Combination Therapy

No OS Signal in Axitinib + Avelumab Combination Therapy

kidneycancer

1 year
676 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School Discusses Elaborating On Frontline Therapies. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.
Up Next Autoplay